1.56

0.00% 0.00

60 Degrees Pharmaceuticals Inc (SXTP)

Overview News Price History Why SXTP Down? Discussions Forecast

60 Degrees Pharmaceuticals Inc stock is traded at $1.56, with a volume of 17,670. It is up +0.00% in the last 24 hours and up +13.04% over the past month. 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

Previous Close:

$1.56

Open:

$1.61

24h Volume:

17,670

Relative Volume:

0.14

Market Cap:

$4.15M

Revenue:

$1.31M

Net Income/Loss:

$-7.56M

P/E Ratio:

-0.1516

EPS:

-10.2926

Net Cash Flow:

$-8.25M

1W Performance:

-8.77%

1M Performance:

+13.04%

6M Performance:

-25.91%

1Y Performance:

-85.06%

1-Day Range:

$1.492

$1.61

1-Week Range:

$1.46

$1.78

52-Week Range:

$1.22

$10.56

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name

60 Degrees Pharmaceuticals Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

202-327-5422

Address

1025 CONNECTICUT AVENUE NW, WASHINGTON

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SXTP's Discussions on Twitter

Compare SXTP vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SXTP 60 Degrees Pharmaceuticals Inc	1.56	4.15M	1.31M	-7.56M	-8.25M	-10.29
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News

Jul 11, 2026

Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 11, 2026

Jul 10, 2026

60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView

Jul 10, 2026

Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 10, 2026

Jul 09, 2026

60 Degrees Pharmaceuticals (NASDAQ: SXTP) Files 8-K Report Detailing Company Updates and Security Information - Minichart

Jul 09, 2026

Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 09, 2026

Interim Trial Plan Finalized for Tafenoquine Babesiosis Study - TipRanks

Jul 09, 2026

60 Degrees Pharmaceuticals readies interim analysis plan for tafenoquine babesiosis trial - TradingView

Jul 09, 2026

60 Degrees Pharmaceuticals (SXTP) sets tafenoquine babesiosis interim analysis and sNDA path - Stock Titan

Jul 09, 2026

Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jul 09, 2026

Jul 08, 2026

60 Degrees Pharmaceuticals to Advance Castanospermine for Tick-Borne Diseases Through Florida State University Deal - Moomoo

Jul 08, 2026

60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases - Yahoo Finance

Jul 08, 2026

Jul 07, 2026

Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 07, 2026

Jul 06, 2026

Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 06, 2026

Jul 03, 2026

SXTP | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative

Jul 03, 2026

SXTPW | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative

Jul 03, 2026

Jul 02, 2026

Equity plan hike and reverse split up for 60 Degrees (SXTP) shareholder vote - Stock Titan

Jul 02, 2026

Jul 01, 2026

60 Degrees Pharma babesiosis study clears safety review - Investing.com UK

Jul 01, 2026

60 Degrees Pharma babesiosis study clears safety review By Investing.com - Investing.com Nigeria

Jul 01, 2026

60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue - Yahoo Finance Singapore

Jul 01, 2026

Safety board backs 60 Degrees Pharma's babesiosis trial continuation - Stock Titan

Jul 01, 2026

Jun 28, 2026

SXTP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 28, 2026

Jun 27, 2026

SXTP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026

Jun 26, 2026

60 Degrees Pharmaceuticals, Inc. Actuals & Estimates (BOATS:SXTP) - TradingView

Jun 26, 2026